Our assays using human and murine tumor cell lines of various origins, including pancreatic, colorectal, and prostate adenocarcinoma, melanoma, and myeloma, point to iNOS-mediated macrophage cytotoxicity as a broadly applicable mechanism of tumor killing. The gene discussed is NOS2; the disease is prostate adenocarcinoma.